Real-time enrollment status for this thyroid eye disease, ted clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 3:22 PM UTC
| NCT Number | NCT07753603 |
| Recruiting Status | Recruiting |
| Condition | Thyroid Eye Disease, TED |
| Phase | PHASE3 |
| Target Enrollment | 130 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Sling Therapeutics, Inc. |
| Last Updated on CT.gov | October 19, 2026 (15 hours ago) |
As of October 19, 2026: Clinical trial NCT07753603 is currently recruiting participants. This phase3 study for thyroid eye disease, ted is actively seeking new participants at 18 locations across the United States. The study is sponsored by Sling Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07753603 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07753603 was last updated 15 hours ago (October 19, 2026). HelloStudys verifies this status automatically.